Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials (Q44150427)

30 November 2017

title

Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials (English)

1 reference

30 November 2017

0 references

Pichia pastoris

1 reference

1 reference

Lanling Zou

1

1 reference

30 November 2017

Aaron P Miles

series ordinal

2

1 reference

30 November 2017

Jin Wang

series ordinal

3

1 reference

30 November 2017

Anthony W Stowers

series ordinal

4

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

30 November 2017

1 reference

30 November 2017

volume

21

1 reference

30 November 2017

issue

15

1 reference

30 November 2017

page(s)

1650-1657

1 reference

Malaria transmission-blocking vaccines

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900701-6

7 January 2021

Current developments in malaria transmission-blocking vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900701-6

7 January 2021

Production, purification and immunogenicity of a malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast and purified using nickel-NTA agarose

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900701-6

7 January 2021

A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900701-6

7 January 2021

Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900701-6

7 January 2021

Recombinant Pfs25 protein of plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900701-6

7 January 2021

A region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900701-6

7 January 2021

Saccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent Plasmodium falciparum transmission-blocking antibodies in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900701-6

7 January 2021

Plasmodium falciparum: immunogenicity of alum-adsorbed clinical-grade TBV25-28, a yeast-secreted malaria transmission-blocking vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900701-6

7 January 2021

Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900701-6

7 January 2021

Antibodies to Plasmodium vivax transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 do not show synergism

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900701-6

7 January 2021

Large-scale purification and characterization of malaria vaccine candidate antigen Pvs25H for use in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900701-6

7 January 2021

A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900701-6

7 January 2021

Induction of plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900701-6

7 January 2021

Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant Pfs25.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900701-6

7 January 2021

10.1016/S0264-410X(02)00701-6

Identifiers

DOI

1 reference

30 November 2017

1 reference